Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) General Information

Description

Worldwide distribution rights of 2 specialty drugs. The rights allows production and sale of Buccastem, used for the treatment of nausea and vomiting, and Timodine, a anti-fungal and anti-bacterial skin cream used for treating inflamed and infected skin conditions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 103 - 105 Bath Road
  • Slough SL1 3UH
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Alliance Pharma
Corporate Office
  • 103 - 105 Bath Road
  • Slough SL1 3UH
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.

Request a free trial

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.

Request a free trial

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) FAQs

  • Where is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) headquartered?

    Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is headquartered in Slough, United Kingdom.

  • What industry is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) in?

    Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)’s primary industry is Buildings and Property.

  • Is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) a private or public company?

    Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is a Private company.

  • What is the current valuation of Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)?

    The current valuation of Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is .

  • What is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)’s current revenue?

    The current revenue for Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is .

  • Who are Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)’s investors?

    Reckitt Benckiser Group has invested in Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands).

  • When was Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) acquired?

    Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) was acquired on 18-Aug-2009.

  • Who acquired Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)?

    Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) was acquired by Alliance Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »